Hims & Hers Health (HIMS) Enterprise Value (2019 - 2026)

Hims & Hers Health (HIMS) has 8 years of Enterprise Value data on file, last reported at -$750.9 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value fell 132.71% year-over-year to -$750.9 million; the trailing twelve-month figure through Mar 2026 stood at -$750.9 million (down 132.71% YoY), and the FY2025 full-year result was -$577.5 million, down 92.34% from the prior year.
• Enterprise Value slipped to -$750.9 million in Q1 2026, from -$577.5 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$179.6 million in Q4 2022 to a low of -$1.1 billion in Q2 2025.
• A 5-year average of -$352.8 million and a median of -$221.0 million in 2023 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value surged 38.56% in 2022 and sank 403.59% in 2025, its largest moves.
• Tracing HIMS's Enterprise Value over 5 years: stood at -$179.6 million in 2022, then fell by 23.02% to -$221.0 million in 2023, then plunged by 35.87% to -$300.3 million in 2024, then slumped by 92.34% to -$577.5 million in 2025, then tumbled by 30.02% to -$750.9 million in 2026.
• Business Quant data shows HIMS's Enterprise Value at -$750.9 million in Q1 2026, -$577.5 million in Q4 2025, and -$629.7 million in Q3 2025.